Another new Brexit thread

Status
Not open for further replies.
No, he is saying it will be expensive and a duplication of effort. The same will be true of chemicals. All Brexit does is add layers of administrative burdens on companies be it through extra regulatory compliance and/or customs procedures.

The money we don't send to the EU is spent replicating the services the EU did on our behalf while losing seamless access to the European Single Market and adding costs and inefficiencies to UK industry.

We are also paying the EU £39 billion and creating internal trade barriers.

Yay.
Yeah yeah yeah, everything will be harder and more expensive but...finally the shackles are off - our sovereignty reclaimed - and ...


Don’t you??
 
I'm well aware we are where we are and no "harking back" to what should have been said or understood in 2016 provides no comfort. Interesting that current polls suggest that many people who voted for Brexit now view things differently though.

Hopefully we'll hear no more from you about May and Robbins attempts to broker a Brexit deal as that is also in the past and we can focus on the very interesting ongoing negotiations.
Nope - you will hear much more from me about May and Robbins because their utter incompetence happened post the referendum and continued upto and including 2019.

It is explicitly their fault that the UK’s position was so badly undermined and we will be paying a price for their incompetence for many years to come

But thanks - you remind of the need - given recent developments - to point out the conditions required before we would see movement from the EU

Another view to have been proven totally correct
 
No, he is saying it will be expensive and a duplication of effort. The same will be true of chemicals. All Brexit does is add layers of administrative burdens on companies be it through extra regulatory compliance and/or customs procedures.

The money we don't send to the EU is spent replicating the services the EU did on our behalf while losing seamless access to the European Single Market and adding costs and inefficiencies to UK industry.

We are also paying the EU £39 billion and creating internal trade barriers.

Yay.
So by no means a disaster/end of the world then? - Excellent.
 
Nope - you will hear much more from me about May and Robbins because their utter incompetence happened post the referendum and continued upto and including 2019.

It is explicitly their fault that the UK’s position was so badly undermined and we will be paying a price for their incompetence for many years to come

But thanks - you remind of the need - given recent developments - to point out the conditions required before we would see movement from the EU

Another view to have been proven totally correct

Lol
 
Nope - you will hear much more from me about May and Robbins because their utter incompetence happened post the referendum and continued upto and including 2019.

It is explicitly their fault that the UK’s position was so badly undermined and we will be paying a price for their incompetence for many years to come

But thanks - you remind of the need - given recent developments - to point out the conditions required before we would see movement from the EU

Another view to have been proven totally correct
181
 
Are you saying it is being funded and resourced from existing budgets and people that could be better used on patient care?
Budget will have been moved from other functions/initiatives to cover it. Where the funds are moved from, and whether that might negatively impact patient care, would be down to individual company decisions.

Regulatory professionals I work with in UK are frazzled. Ask them to work with you and they look horrified. Timescales for their input into projects - some impacting patient care - have gone from 6 weeks to 6 months.

An extra regulatory staff pressure is better people heading off to the continent. Many European corporate regulatory functions were based in UK because the EMA was in London. These are moving to the EU now and taking many good people with them.

I wouldn't like to think the immediate patient care interface has been impacted, but "patient care" covers a very wide set of activities which generally need to be approved by... regulatory.
 
So by no means a disaster/end of the world then? - Excellent.
Be careful before you relax in a golden glow. A future adrift from the EMA offers many uncertainties for patients and clinicians. A couple of examples:

EMA regulates and administers many international, multi-centre drug trials. UK risks being peripheral participants in a future outside EMA. Reduces UK patient access to cutting-edge medicines and pisses off influential UK clinical consultants. Top docs are driven by research and consequently influence clinical opinion throughout UK. If these good docs want good research, they might follow their ambition abroad, seriously impacting quality in UK clinical practice and patient care. What happens to EMA trials UK is involved with after 31 December? I don't know.

Expensive, niche medicines (e.g. cancer monoclonals) are often difficult to access for UK NHS patients. Currently approved for UK use under EMA umbrella, but NHS funding is highly restricted or not available at all. The UK is a tiny accessible patient pool in global terms for such drugs. ROI in UK is already poor for these. Future submissions for MHRA approval of new drugs would be a costly process. Might not make commercial sense to even bother with submission. Then there's no chance of UK patients receiving such drugs.

It's really important that we retain the most inclusive relationship with the EMA we possibly can, but inclusive is not a fashionable flavour right now.
 
Last edited:
Status
Not open for further replies.

Don't have an account? Register now and see fewer ads!

SIGN UP
Back
Top
  AdBlock Detected
Bluemoon relies on advertising to pay our hosting fees. Please support the site by disabling your ad blocking software to help keep the forum sustainable. Thanks.